Comment on

• A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndrome.

  Morris PE, Papadakos P, Russell JA, Wunderink R, Schuster DP, Truwit JD, Vincent JL, Bernard GR. Morris PE, et al. Crit Care Med. 2008 Mar;36(3):782-8. doi: 10.1097/CCM.0B013E318164E7E4. Crit Care Med. 2008. PMID: 18209670 Clinical Trial.